Slingshot members are tracking this event:

Genmab/Novartis' Arzerra (Ofatumumab) as Maintenance Therapy for Relapsed chronic lymphocytic leukemia PDUFA target date set to January 21, 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
NVS Community voting in process
OMX: GEN Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 19, 2016
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Pdufa, Arzerra, Oftamumab, Relapsed Chronic Lymphocytic Leukemia